Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
1.010
-0.060 (-5.61%)
Mar 6, 2026, 10:05 AM EST - Market open
Citius Oncology Market Cap
Citius Oncology has a market cap or net worth of $89.16 million as of March 6, 2026. Its market cap has increased by 3.84% in one year.
Market Cap
89.16M
Enterprise Value
90.96M
1-Year Change
3.84%
Ranking
Category
Stock Price
$1.01
Market Cap Chart
Since December 8, 2022, Citius Oncology's market cap has decreased from $90.21M to $89.16M, a decrease of -1.17%. That is a compound annual growth rate of -0.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 94.45M | 11.39% |
| Dec 31, 2025 | 84.80M | 3.05% |
| Dec 31, 2024 | 82.29M | -15.88% |
| Dec 29, 2023 | 97.81M | 7.68% |
| Dec 30, 2022 | 90.84M | 0.69% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aurora Cannabis | 207.06M |
| Organigram Global | 196.12M |
| Anika Therapeutics | 190.96M |
| BGM Group | 187.64M |
| Alpha Teknova | 118.43M |
| Cardiol Therapeutics | 110.03M |
| Assertio Holdings | 76.68M |
| Cumberland Pharmaceuticals | 53.02M |